Cargando…
Clinical Usefulness of the 2010 Clinical and Laboratory Standards Institute Revised Breakpoints for Cephalosporin Use in the Treatment of Bacteremia Caused by Escherichia coli or Klebsiella spp.
We investigated the clinical usefulness of the revised 2010 Clinical and Laboratory Standards Institute (CLSI) breakpoints for Escherichia coli and Klebsiella spp. Of 2,623 patients with bacteremia caused by E. coli or Klebsiella spp., 573 who had been treated appropriately with cephalosporin based...
Autores principales: | Ku, Nam Su, Chung, Hae-Sun, Choi, Jun Yong, Yong, Dongeun, Lee, Kyungwon, Kim, June Myung, Chong, Yunsop |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4352463/ https://www.ncbi.nlm.nih.gov/pubmed/25793209 http://dx.doi.org/10.1155/2015/831074 |
Ejemplares similares
-
The Clinical Evaluation of Third-generation Cephalosporins As Definitive Therapy for Enterobacter spp. and Klebsiella aerogenes Bacteremia
por: Kobayashi, Kazuhiro, et al.
Publicado: (2022) -
Multidrug-Resistant Acinetobacter spp.: Increasingly Problematic Nosocomial Pathogens
por: Lee, Kyungwon, et al.
Publicado: (2011) -
High Prevalence of Ceftazidime-Resistant Klebsiella pneumoniae and Increase of Imipenem-Resistant Pseudomonas aeruginosa and Acinetobacter spp. in Korea: a KONSAR Program in 2004
por: Lee, Kyungwon, et al.
Publicado: (2006) -
Further Increase of Vancomycin-Resistant Enterococcus faecium, Amikacin- and Fluoroquinolone-Resistant Klebsiella pneumoniae, and Imipenem-Resistant Acinetobacter spp. in Korea: 2003 KONSAR Surveillance
por: Lee, Kyungwon, et al.
Publicado: (2006) -
Clinical Impact of Revised Cefepime Breakpoint in Patients With Enterobacteriaceae Bacteremia
por: Foong, Kap Sum, et al.
Publicado: (2019)